Skip to main content

Table 4 Drug company R&D and non-R&D payments disclosed under the JPMA Transparency Guidelines and the ABPI Code (2018)

From: International comparison of pharmaceutical industry payment disclosures in the UK and Japan: implications for self-regulation, public regulation, and transparency

JPMA payment categories

Value of payments, ($)

Value of payments –merged JPMA categories ( $)

Value of payments – merged JPMA – named recipients ($)

ABPI payment categories

Total value of payments ($)

Value of payments – named recipients ($)

Research and development (A)

1,276,805,878.8

1,276,805,878.8 (100%)

1,236,732,890.2 (96.9%)

Research and development

493,470,880.7 (100%)

0.0 (0%)

Scholarship donations (B1)

167,048,419.4

217,575,581.0 (100%)

217,575,581.0 (100%)

Donations and Grants

35,118,661.8 (100%)

35,082,449.0 (99.9%)1

General donations (B2)

34,517,905.3

Donations to academic and other societies (B3)

16,009,256.3

Expenses related to co-sponsored conferences (B4)

76,063,460.5

845,194,783.3 (100%)

76,063,460.5 (10.0%)

Contributions to costs of events

55,207,855.0 (100%)

48,774,249.8 (88.3%)

Expenses for lecture conferences (D1)

769,131,322.9

Lecture fees (C1)

211,419,118.7

248,042,904.90 (100%)

248,042,904.90 (100%)

Fees for service and consultancy

74,931,974.0 (100%)

53,459,921.3 (71.3%)

Manuscript writing fee/supervising fees (C2)

8,973,254.3

Consulting/commissioning fees (C3)

28,934,542.5

Other (C)2

161,435.2

Other expenses related to academic research support expenses (B5)

11,203,780.9

12,621,124.4 (100%)

11,203,780.9 (88.8%)

No corresponding ABPI payment categories

Other Information provision-related expenses (D4)

1,417,343.5

Explanation meeting expenses (D2)

275,045,094.6

275,045,094.6 (100%)

0.0 (0%)

Excluded from or prohibited by disclosure requirements

Expenses for provision of literature and other products (D3)

69,080,312.8

69,080,312.8 (100%)

0.0 (0%)

Other expenses (E)

42,814,875.4

42,814,875.4 (100%)

0.0 (0%)

No corresponding ABPI payment categories

No corresponding JPMA payment categories

Joint working

7,003,799.0 (100%)

7,003,799.0 (100%)

Total

2,988,626,001.0 (100%)

2,988,626,001.0 (100%)

1,791,064,063.3 (59.9%)

Total

665,733,170.5 (100%)

144,320,419.0 (21.7%)

  1. 1 Until 2019 ABPI members could consent healthcare organisations before disclosing their payments but few companies chose to do so. Consenting healthcare organisations is currently prohibited
  2. Originally, Category C did not have an "Other" item, but one company recorded the amount as "Other”